Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Hosted on MSN14m
Kymera Provides Pipeline Objectives for 2025, Stock Gains
Kymera Therapeutics, Inc. KYMR announced its business goals for 2025, along with anticipated progress on its pipeline of ...
MM&M59m
Vicks retains top spot among Rx, OTC pharma brands in December
Vicks once again achieved the top monthly spot for TV impressions, while iSpot noted that pharma brands generated more year-over-year returns from sports and news cables compared to 2023.
Armed robbery in Revesby43m
Xenon Gas to Be Tested in Alzheimer's Clinical Trial
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but ...
The Pharma Letter12m
Owlstone secures $27 million in series E funding
Owlstone Medical secures $27M in series E funding to advance breath-based diagnostics and commercialization. Led by Ventura ...